|
|
|
Volumn 64, Issue 11, 2001, Pages 1863-1866
|
|
Quinupristin-dalfopristin: A new antibiotic for severe gram-positive infections
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTINEOPLASTIC AGENT;
AZTREONAM;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CEFAZOLIN;
CORTICOSTEROID;
CYCLOSPORIN A;
DALFOPRISTIN PLUS QUINUPRISTIN;
DELAVIRDINE;
DIAZEPAM;
DILTIAZEM;
DOCETAXEL;
IMMUNOSUPPRESSIVE AGENT;
INDINAVIR;
LIDOCAINE;
METHYLPREDNISOLONE;
MEVINOLIN;
MIDAZOLAM;
NEVIRAPINE;
NIFEDIPINE;
OXACILLIN;
PACLITAXEL;
RITONAVIR;
STREPTOGRAMIN;
TACROLIMUS;
UNINDEXED DRUG;
VANCOMYCIN;
VERAPAMIL;
VINCA ALKALOID;
ADULT;
AGED;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
ANTIMICROBIAL ACTIVITY;
ARTHRALGIA;
BACTERIAL INFECTION;
CHILD;
CLINICAL TRIAL;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG SAFETY;
ENTEROCOCCUS FAECIUM;
GRAM POSITIVE BACTERIUM;
HOSPITAL INFECTION;
HUMAN;
MAJOR CLINICAL STUDY;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MYALGIA;
NONHUMAN;
PHASE 3 CLINICAL TRIAL;
REVIEW;
TREATMENT OUTCOME;
WOUND INFECTION;
DRUG THERAPY, COMBINATION;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HUMANS;
VIRGINIAMYCIN;
|
|
EID: 0035629457
PISSN: 0002838X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (29)
|
|
References (9)
|
